Resolution of sweating after switching from transdermal fentanyl to oral morphine sulphate.
Shah
S
S
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D005283:Fentanyl / Q000009:adverse effects*; D006801:Humans; D006945:Hyperhidrosis / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000556:secondary; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D010146:Pain / Q000517:prevention & control; D012004:Rectal Neoplasms / Q000628:therapy
D000701:Analgesics, Opioid; D009020:Morphine; D005283:Fentanyl